We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The UK pharmaceutical industry has struck a unique deal with the health service in Manchester that it says will transform patients' access to medicines.
In an effort to improvetheinternational response to combatting multidrug-resistant TB, MPP andJohns Hopkins University signlicensing agreement forinvestigational treatmentsutezolid